Skip to main content
. 2003 Oct 20;2003(4):CD001332. doi: 10.1002/14651858.CD001332

Killestein 2002.

Methods Cross‐over study (4 week treatment periods)
Participants 16 MS patients
Interventions 2.5‐5mg THC v. C. sativa plant extract v. placebo
Outcomes Ashworth score, EDSS, MS Functional composite score (timed walk, 9 hole peg test, PASAT), MS Fatigue Severity Scale, SF36, visual analogue scales
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear